ECM
AZN icon

ExodusPoint Capital Management’s AstraZeneca AZN Stock Holding History

ExodusPoint Capital Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.1M Buy
106,832
+32,704
+44% +$6.31M 0.17% 88
2025
Q4 		$13.6M Buy
74,128
+66,634
+889% +$11.7M 0.11% 176
2025
Q3 		$1.15M Buy
+7,494
New +$1.13M 0.01% 913
2024
Q2 		– Sell
-72,678
Closed -$9.85M – 1530
2024
Q1 		$9.85M Buy
72,678
+24,837
+52% +$3.29M 0.08% 210
2023
Q4 		$6.44M Sell
47,841
-77,750
-62% -$10.1M 0.04% 292
2023
Q3 		$17M Buy
125,591
+115,521
+1,147% +$15.8M 0.16% 119
2023
Q2 		$1.44M Sell
10,070
-101,393
-91% -$14.9M 0.01% 949
2023
Q1 		$15.5M Buy
+111,463
New +$15M 0.13% 171
2022
Q4 		– Sell
-28,958
Closed -$3.18M – 1634
2022
Q3 		$3.18M Buy
+28,958
New +$3.67M 0.04% 571
2022
Q2 		– Sell
-3,063
Closed -$406K – 1930
2022
Q1 		$406K Sell
3,063
-197
-6% -$23.6K 0.01% 1644
2021
Q4 		$380K Sell
3,260
-33,582
-91% -$3.95M ﹤0.01% 1554
2021
Q3 		$4.42M Buy
36,842
+5,046
+16% +$587K 0.06% 438
2021
Q2 		$3.81M Buy
+31,796
New +$3.49M 0.04% 452
2021
Q1 		– Sell
-8,406
Closed -$840K – 2115
2020
Q4 		$840K Sell
8,406
-2,113
-20% -$224K 0.01% 952
2020
Q3 		$1.15M Buy
10,519
+7,500
+248% +$834K 0.02% 621
2020
Q2 		$319K Buy
+3,019
New +$312K 0.01% 1290
2019
Q3 		– Sell
-7,007
Closed -$578K – 1331
2019
Q2 		$578K Buy
7,007
+1,460
+26% +$114K 0.02% 407
2019
Q1 		$449K Buy
+5,547
New +$437K 0.03% 361

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

ExodusPoint Capital Management's AZN Position: Q1 2026 in Review

ExodusPoint Capital Management increased its AstraZeneca (AZN) stake by 44% in Q1 2026, buying an estimated $6.31M and bringing the position to 106,832 shares worth $21.1M. The position accounts for 0.17% of the portfolio, ranked #88.

ExodusPoint Capital Management first reported a position in AZN in Q1 2019 and has held it in 18 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • ExodusPoint Capital Management held 106,832 shares of AstraZeneca worth $21.1M as of Q1 2026.
  • ExodusPoint Capital Management bought 32,704 AstraZeneca shares in Q1 2026, an estimated $6.31M.
  • AstraZeneca made up 0.17% of ExodusPoint Capital Management's portfolio in Q1 2026, its #88 holding.
  • ExodusPoint Capital Management first reported a position in AstraZeneca in Q1 2019 and has held it in 18 quarters since.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.